MTOR and colorectal carcinoma: As to ASP, potential mechanisms involved in its CRC anticancer effect include activation of AMPK/inhibition of mTOR signaling and inhibition of inflammatory components such as COX-1/COX-2 and nuclear factor kappa B (NFκB) [3,4,5,14,29]).